Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantomix was an Israeli life sciences company that developed the WET-SEM technology, enabling the imaging of wet samples in their native state using standard scanning electron microscopes (SEM). The company's primary product line consisted of QX capsules, which featured a thin, electron-transparent membrane that protected liquid samples from the microscope's vacuum while allowing electron beam penetration. This innovation bypassed the need for traditional, time-consuming sample preparation methods like dehydration, critical point drying, or metal coating. Quantomix's solutions were applied across various fields, including cell biology, histology, and industrial fluid analysis. The technology allowed researchers to observe cells and tissues with high resolution while maintaining their original hydration and structure. Although the company is no longer active, its WET-SEM platform represented a significant advancement in electron microscopy for biological applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantomix.